 | • レポートコード：MRC2Q12-18992 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、ジヒドロピリジンカルシウムチャネルブロッカーの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にジヒドロピリジンカルシウムチャネルブロッカーのグローバル市場のxxx％を占める「ノルバスク」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「高血圧症」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 ジヒドロピリジンカルシウムチャネルブロッカーの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのジヒドロピリジンカルシウムチャネルブロッカー市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ジヒドロピリジンカルシウムチャネルブロッカーのグローバル主要プレイヤーには、Pfizer、AstraZeneca、Abbott、Novartis、Sanofi、Sine Promod、Desano、Kang Lisheng Pharma、Guo Guang Pharma、Baiyunshan Pharma、Dawnraysなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ジヒドロピリジンカルシウムチャネルブロッカー市場は、種類と用途によって区分されます。世界のジヒドロピリジンカルシウムチャネルブロッカー市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ノルバスク、プレンディル、ダイナサーク、カルデン、その他 【用途別セグメント】 高血圧症、冠動脈疾患、不整脈、心筋症、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ジヒドロピリジンカルシウムチャネルブロッカー製品概要 - 種類別市場（ノルバスク、プレンディル、ダイナサーク、カルデン、その他） - 用途別市場（高血圧症、冠動脈疾患、不整脈、心筋症、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のジヒドロピリジンカルシウムチャネルブロッカー販売量予測2017-2028 - 世界のジヒドロピリジンカルシウムチャネルブロッカー売上予測2017-2028 - ジヒドロピリジンカルシウムチャネルブロッカーの地域別販売量 - ジヒドロピリジンカルシウムチャネルブロッカーの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ジヒドロピリジンカルシウムチャネルブロッカー販売量 - 主要メーカー別ジヒドロピリジンカルシウムチャネルブロッカー売上 - 主要メーカー別ジヒドロピリジンカルシウムチャネルブロッカー価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ノルバスク、プレンディル、ダイナサーク、カルデン、その他） - ジヒドロピリジンカルシウムチャネルブロッカーの種類別販売量 - ジヒドロピリジンカルシウムチャネルブロッカーの種類別売上 - ジヒドロピリジンカルシウムチャネルブロッカーの種類別価格 ・用途別市場規模（高血圧症、冠動脈疾患、不整脈、心筋症、その他） - ジヒドロピリジンカルシウムチャネルブロッカーの用途別販売量 - ジヒドロピリジンカルシウムチャネルブロッカーの用途別売上 - ジヒドロピリジンカルシウムチャネルブロッカーの用途別価格 ・北米市場 - 北米のジヒドロピリジンカルシウムチャネルブロッカー市場規模（種類別、用途別） - 主要国別のジヒドロピリジンカルシウムチャネルブロッカー市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのジヒドロピリジンカルシウムチャネルブロッカー市場規模（種類別、用途別） - 主要国別のジヒドロピリジンカルシウムチャネルブロッカー市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のジヒドロピリジンカルシウムチャネルブロッカー市場規模（種類別、用途別） - 主要国別のジヒドロピリジンカルシウムチャネルブロッカー市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のジヒドロピリジンカルシウムチャネルブロッカー市場規模（種類別、用途別） - 主要国別のジヒドロピリジンカルシウムチャネルブロッカー市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのジヒドロピリジンカルシウムチャネルブロッカー市場規模（種類別、用途別） - 主要国別のジヒドロピリジンカルシウムチャネルブロッカー市場規模（トルコ、サウジアラビア） ・企業情報 Pfizer、AstraZeneca、Abbott、Novartis、Sanofi、Sine Promod、Desano、Kang Lisheng Pharma、Guo Guang Pharma、Baiyunshan Pharma、Dawnrays ・産業チェーン及び販売チャネル分析 - ジヒドロピリジンカルシウムチャネルブロッカーの産業チェーン分析 - ジヒドロピリジンカルシウムチャネルブロッカーの原材料 - ジヒドロピリジンカルシウムチャネルブロッカーの生産プロセス - ジヒドロピリジンカルシウムチャネルブロッカーの販売及びマーケティング - ジヒドロピリジンカルシウムチャネルブロッカーの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ジヒドロピリジンカルシウムチャネルブロッカーの産業動向 - ジヒドロピリジンカルシウムチャネルブロッカーのマーケットドライバー - ジヒドロピリジンカルシウムチャネルブロッカーの課題 - ジヒドロピリジンカルシウムチャネルブロッカーの阻害要因 ・主な調査結果 |
Dihydropyridine (DHP) calcium channel blockers are derived from the molecule dihydropyridine and often used to reduce systemic vascular resistance and arterial pressure. Sometimes when they are used to treat angina, the vasodilation and hypotension can lead to reflex tachycardia, which can be detrimental for patients with ischemicsymptoms because of the resulting increase in myocardial oxygen demand. Dihydropyridine calcium channel blockers can worsen proteinuria in patients with nephropathy.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Dihydropyridine Calcium Channel Blocker is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Dihydropyridine Calcium Channel Blocker is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Dihydropyridine Calcium Channel Blocker is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Dihydropyridine Calcium Channel Blocker include Pfizer, AstraZeneca, Abbott, Novartis, Sanofi, Sine Promod, Desano, Kang Lisheng Pharma and Guo Guang Pharma, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Dihydropyridine Calcium Channel Blocker manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Dihydropyridine Calcium Channel Blocker market. Further, it explains the major drivers and regional dynamics of the global Dihydropyridine Calcium Channel Blocker market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Pfizer
AstraZeneca
Abbott
Novartis
Sanofi
Sine Promod
Desano
Kang Lisheng Pharma
Guo Guang Pharma
Baiyunshan Pharma
Dawnrays
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Dihydropyridine Calcium Channel Blocker Segment by Type
Norvasc
Plendil
DynaCirc
Cardene
Others
Dihydropyridine Calcium Channel Blocker Segment by Application
Hypertension
Coronary Artery Disease
Arrhythmia
Cardiomyopathy
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Dihydropyridine Calcium Channel Blocker market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Dihydropyridine Calcium Channel Blocker, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Dihydropyridine Calcium Channel Blocker, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Dihydropyridine Calcium Channel Blocker, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dihydropyridine Calcium Channel Blocker sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Dihydropyridine Calcium Channel Blocker market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Dihydropyridine Calcium Channel Blocker sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, AstraZeneca, Abbott, Novartis, Sanofi, Sine Promod, Desano, Kang Lisheng Pharma and Guo Guang Pharma, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Dihydropyridine Calcium Channel Blocker in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Dihydropyridine Calcium Channel Blocker manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dihydropyridine Calcium Channel Blocker sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Dihydropyridine Calcium Channel Blocker Product Introduction
1.2 Market by Type
1.2.1 Global Dihydropyridine Calcium Channel Blocker Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Norvasc
1.2.3 Plendil
1.2.4 DynaCirc
1.2.5 Cardene
1.2.6 Others
1.3 Market by Application
1.3.1 Global Dihydropyridine Calcium Channel Blocker Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hypertension
1.3.3 Coronary Artery Disease
1.3.4 Arrhythmia
1.3.5 Cardiomyopathy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dihydropyridine Calcium Channel Blocker Sales Estimates and Forecasts 2017-2028
2.2 Global Dihydropyridine Calcium Channel Blocker Revenue Estimates and Forecasts 2017-2028
2.3 Global Dihydropyridine Calcium Channel Blocker Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Dihydropyridine Calcium Channel Blocker Sales by Region
2.4.1 Global Dihydropyridine Calcium Channel Blocker Sales by Region (2017-2022)
2.4.2 Global Sales Dihydropyridine Calcium Channel Blocker by Region (2023-2028)
2.5 Global Dihydropyridine Calcium Channel Blocker Revenue by Region
2.5.1 Global Dihydropyridine Calcium Channel Blocker Revenue by Region (2017-2022)
2.5.2 Global Dihydropyridine Calcium Channel Blocker Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Dihydropyridine Calcium Channel Blocker Sales by Manufacturers
3.1.1 Global Top Dihydropyridine Calcium Channel Blocker Manufacturers by Sales (2017-2022)
3.1.2 Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dihydropyridine Calcium Channel Blocker in 2021
3.2 Global Dihydropyridine Calcium Channel Blocker Revenue by Manufacturers
3.2.1 Global Dihydropyridine Calcium Channel Blocker Revenue by Manufacturers (2017-2022)
3.2.2 Global Dihydropyridine Calcium Channel Blocker Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Dihydropyridine Calcium Channel Blocker Revenue in 2021
3.3 Global Dihydropyridine Calcium Channel Blocker Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Dihydropyridine Calcium Channel Blocker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Dihydropyridine Calcium Channel Blocker Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dihydropyridine Calcium Channel Blocker Sales by Type
4.1.1 Global Dihydropyridine Calcium Channel Blocker Historical Sales by Type (2017-2022)
4.1.2 Global Dihydropyridine Calcium Channel Blocker Forecasted Sales by Type (2023-2028)
4.1.3 Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Type (2017-2028)
4.2 Global Dihydropyridine Calcium Channel Blocker Revenue by Type
4.2.1 Global Dihydropyridine Calcium Channel Blocker Historical Revenue by Type (2017-2022)
4.2.2 Global Dihydropyridine Calcium Channel Blocker Forecasted Revenue by Type (2023-2028)
4.2.3 Global Dihydropyridine Calcium Channel Blocker Revenue Market Share by Type (2017-2028)
4.3 Global Dihydropyridine Calcium Channel Blocker Price by Type
4.3.1 Global Dihydropyridine Calcium Channel Blocker Price by Type (2017-2022)
4.3.2 Global Dihydropyridine Calcium Channel Blocker Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Dihydropyridine Calcium Channel Blocker Sales by Application
5.1.1 Global Dihydropyridine Calcium Channel Blocker Historical Sales by Application (2017-2022)
5.1.2 Global Dihydropyridine Calcium Channel Blocker Forecasted Sales by Application (2023-2028)
5.1.3 Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Application (2017-2028)
5.2 Global Dihydropyridine Calcium Channel Blocker Revenue by Application
5.2.1 Global Dihydropyridine Calcium Channel Blocker Historical Revenue by Application (2017-2022)
5.2.2 Global Dihydropyridine Calcium Channel Blocker Forecasted Revenue by Application (2023-2028)
5.2.3 Global Dihydropyridine Calcium Channel Blocker Revenue Market Share by Application (2017-2028)
5.3 Global Dihydropyridine Calcium Channel Blocker Price by Application
5.3.1 Global Dihydropyridine Calcium Channel Blocker Price by Application (2017-2022)
5.3.2 Global Dihydropyridine Calcium Channel Blocker Price Forecast by Application (2023-2028)
6 North America
6.1 North America Dihydropyridine Calcium Channel Blocker Market Size by Type
6.1.1 North America Dihydropyridine Calcium Channel Blocker Sales by Type (2017-2028)
6.1.2 North America Dihydropyridine Calcium Channel Blocker Revenue by Type (2017-2028)
6.2 North America Dihydropyridine Calcium Channel Blocker Market Size by Application
6.2.1 North America Dihydropyridine Calcium Channel Blocker Sales by Application (2017-2028)
6.2.2 North America Dihydropyridine Calcium Channel Blocker Revenue by Application (2017-2028)
6.3 North America Dihydropyridine Calcium Channel Blocker Market Size by Country
6.3.1 North America Dihydropyridine Calcium Channel Blocker Sales by Country (2017-2028)
6.3.2 North America Dihydropyridine Calcium Channel Blocker Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Dihydropyridine Calcium Channel Blocker Market Size by Type
7.1.1 Europe Dihydropyridine Calcium Channel Blocker Sales by Type (2017-2028)
7.1.2 Europe Dihydropyridine Calcium Channel Blocker Revenue by Type (2017-2028)
7.2 Europe Dihydropyridine Calcium Channel Blocker Market Size by Application
7.2.1 Europe Dihydropyridine Calcium Channel Blocker Sales by Application (2017-2028)
7.2.2 Europe Dihydropyridine Calcium Channel Blocker Revenue by Application (2017-2028)
7.3 Europe Dihydropyridine Calcium Channel Blocker Market Size by Country
7.3.1 Europe Dihydropyridine Calcium Channel Blocker Sales by Country (2017-2028)
7.3.2 Europe Dihydropyridine Calcium Channel Blocker Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Dihydropyridine Calcium Channel Blocker Market Size by Type
8.1.1 Asia Pacific Dihydropyridine Calcium Channel Blocker Sales by Type (2017-2028)
8.1.2 Asia Pacific Dihydropyridine Calcium Channel Blocker Revenue by Type (2017-2028)
8.2 Asia Pacific Dihydropyridine Calcium Channel Blocker Market Size by Application
8.2.1 Asia Pacific Dihydropyridine Calcium Channel Blocker Sales by Application (2017-2028)
8.2.2 Asia Pacific Dihydropyridine Calcium Channel Blocker Revenue by Application (2017-2028)
8.3 Asia Pacific Dihydropyridine Calcium Channel Blocker Market Size by Region
8.3.1 Asia Pacific Dihydropyridine Calcium Channel Blocker Sales by Region (2017-2028)
8.3.2 Asia Pacific Dihydropyridine Calcium Channel Blocker Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Dihydropyridine Calcium Channel Blocker Market Size by Type
9.1.1 Latin America Dihydropyridine Calcium Channel Blocker Sales by Type (2017-2028)
9.1.2 Latin America Dihydropyridine Calcium Channel Blocker Revenue by Type (2017-2028)
9.2 Latin America Dihydropyridine Calcium Channel Blocker Market Size by Application
9.2.1 Latin America Dihydropyridine Calcium Channel Blocker Sales by Application (2017-2028)
9.2.2 Latin America Dihydropyridine Calcium Channel Blocker Revenue by Application (2017-2028)
9.3 Latin America Dihydropyridine Calcium Channel Blocker Market Size by Country
9.3.1 Latin America Dihydropyridine Calcium Channel Blocker Sales by Country (2017-2028)
9.3.2 Latin America Dihydropyridine Calcium Channel Blocker Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Dihydropyridine Calcium Channel Blocker Market Size by Type
10.1.1 Middle East and Africa Dihydropyridine Calcium Channel Blocker Sales by Type (2017-2028)
10.1.2 Middle East and Africa Dihydropyridine Calcium Channel Blocker Revenue by Type (2017-2028)
10.2 Middle East and Africa Dihydropyridine Calcium Channel Blocker Market Size by Application
10.2.1 Middle East and Africa Dihydropyridine Calcium Channel Blocker Sales by Application (2017-2028)
10.2.2 Middle East and Africa Dihydropyridine Calcium Channel Blocker Revenue by Application (2017-2028)
10.3 Middle East and Africa Dihydropyridine Calcium Channel Blocker Market Size by Country
10.3.1 Middle East and Africa Dihydropyridine Calcium Channel Blocker Sales by Country (2017-2028)
10.3.2 Middle East and Africa Dihydropyridine Calcium Channel Blocker Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Dihydropyridine Calcium Channel Blocker Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Dihydropyridine Calcium Channel Blocker Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Overview
11.3.3 Abbott Dihydropyridine Calcium Channel Blocker Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abbott Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abbott Recent Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Overview
11.4.3 Novartis Dihydropyridine Calcium Channel Blocker Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Dihydropyridine Calcium Channel Blocker Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sanofi Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Sine Promod
11.6.1 Sine Promod Corporation Information
11.6.2 Sine Promod Overview
11.6.3 Sine Promod Dihydropyridine Calcium Channel Blocker Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sine Promod Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sine Promod Recent Developments
11.7 Desano
11.7.1 Desano Corporation Information
11.7.2 Desano Overview
11.7.3 Desano Dihydropyridine Calcium Channel Blocker Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Desano Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Desano Recent Developments
11.8 Kang Lisheng Pharma
11.8.1 Kang Lisheng Pharma Corporation Information
11.8.2 Kang Lisheng Pharma Overview
11.8.3 Kang Lisheng Pharma Dihydropyridine Calcium Channel Blocker Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Kang Lisheng Pharma Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Kang Lisheng Pharma Recent Developments
11.9 Guo Guang Pharma
11.9.1 Guo Guang Pharma Corporation Information
11.9.2 Guo Guang Pharma Overview
11.9.3 Guo Guang Pharma Dihydropyridine Calcium Channel Blocker Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Guo Guang Pharma Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Guo Guang Pharma Recent Developments
11.10 Baiyunshan Pharma
11.10.1 Baiyunshan Pharma Corporation Information
11.10.2 Baiyunshan Pharma Overview
11.10.3 Baiyunshan Pharma Dihydropyridine Calcium Channel Blocker Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Baiyunshan Pharma Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Baiyunshan Pharma Recent Developments
11.11 Dawnrays
11.11.1 Dawnrays Corporation Information
11.11.2 Dawnrays Overview
11.11.3 Dawnrays Dihydropyridine Calcium Channel Blocker Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Dawnrays Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Dawnrays Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dihydropyridine Calcium Channel Blocker Industry Chain Analysis
12.2 Dihydropyridine Calcium Channel Blocker Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dihydropyridine Calcium Channel Blocker Production Mode & Process
12.4 Dihydropyridine Calcium Channel Blocker Sales and Marketing
12.4.1 Dihydropyridine Calcium Channel Blocker Sales Channels
12.4.2 Dihydropyridine Calcium Channel Blocker Distributors
12.5 Dihydropyridine Calcium Channel Blocker Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Dihydropyridine Calcium Channel Blocker Industry Trends
13.2 Dihydropyridine Calcium Channel Blocker Market Drivers
13.3 Dihydropyridine Calcium Channel Blocker Market Challenges
13.4 Dihydropyridine Calcium Channel Blocker Market Restraints
14 Key Findings in The Global Dihydropyridine Calcium Channel Blocker Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Dihydropyridine Calcium Channel Blocker Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Norvasc
Table 3. Major Manufacturers of Plendil
Table 4. Major Manufacturers of DynaCirc
Table 5. Major Manufacturers of Cardene
Table 6. Major Manufacturers of Others
Table 7. Global Dihydropyridine Calcium Channel Blocker Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Dihydropyridine Calcium Channel Blocker Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Dihydropyridine Calcium Channel Blocker Sales by Region (2017-2022) & (K Units)
Table 10. Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Region (2017-2022)
Table 11. Global Dihydropyridine Calcium Channel Blocker Sales by Region (2023-2028) & (K Units)
Table 12. Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Region (2023-2028)
Table 13. Global Dihydropyridine Calcium Channel Blocker Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Dihydropyridine Calcium Channel Blocker Revenue Market Share by Region (2017-2022)
Table 15. Global Dihydropyridine Calcium Channel Blocker Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Dihydropyridine Calcium Channel Blocker Revenue Market Share by Region (2023-2028)
Table 17. Global Dihydropyridine Calcium Channel Blocker Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Dihydropyridine Calcium Channel Blocker Sales Share by Manufacturers (2017-2022)
Table 19. Global Dihydropyridine Calcium Channel Blocker Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Dihydropyridine Calcium Channel Blocker Revenue Share by Manufacturers (2017-2022)
Table 21. Dihydropyridine Calcium Channel Blocker Price by Manufacturers (2017-2022) &(US$/Unit)
Table 22. Global Dihydropyridine Calcium Channel Blocker Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Dihydropyridine Calcium Channel Blocker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dihydropyridine Calcium Channel Blocker as of 2021)
Table 24. Dihydropyridine Calcium Channel Blocker Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Dihydropyridine Calcium Channel Blocker Product Offered
Table 26. Date of Manufacturers Enter into Dihydropyridine Calcium Channel Blocker Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Dihydropyridine Calcium Channel Blocker Sales by Type (2017-2022) & (K Units)
Table 29. Global Dihydropyridine Calcium Channel Blocker Sales by Type (2023-2028) & (K Units)
Table 30. Global Dihydropyridine Calcium Channel Blocker Sales Share by Type (2017-2022)
Table 31. Global Dihydropyridine Calcium Channel Blocker Sales Share by Type (2023-2028)
Table 32. Global Dihydropyridine Calcium Channel Blocker Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Dihydropyridine Calcium Channel Blocker Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Dihydropyridine Calcium Channel Blocker Revenue Share by Type (2017-2022)
Table 35. Global Dihydropyridine Calcium Channel Blocker Revenue Share by Type (2023-2028)
Table 36. Dihydropyridine Calcium Channel Blocker Price by Type (2017-2022) & (US$/Unit)
Table 37. Global Dihydropyridine Calcium Channel Blocker Price Forecast by Type (2023-2028) & (US$/Unit)
Table 38. Global Dihydropyridine Calcium Channel Blocker Sales by Application (2017-2022) & (K Units)
Table 39. Global Dihydropyridine Calcium Channel Blocker Sales by Application (2023-2028) & (K Units)
Table 40. Global Dihydropyridine Calcium Channel Blocker Sales Share by Application (2017-2022)
Table 41. Global Dihydropyridine Calcium Channel Blocker Sales Share by Application (2023-2028)
Table 42. Global Dihydropyridine Calcium Channel Blocker Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Dihydropyridine Calcium Channel Blocker Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Dihydropyridine Calcium Channel Blocker Revenue Share by Application (2017-2022)
Table 45. Global Dihydropyridine Calcium Channel Blocker Revenue Share by Application (2023-2028)
Table 46. Dihydropyridine Calcium Channel Blocker Price by Application (2017-2022) & (US$/Unit)
Table 47. Global Dihydropyridine Calcium Channel Blocker Price Forecast by Application (2023-2028) & (US$/Unit)
Table 48. North America Dihydropyridine Calcium Channel Blocker Sales by Type (2017-2022) & (K Units)
Table 49. North America Dihydropyridine Calcium Channel Blocker Sales by Type (2023-2028) & (K Units)
Table 50. North America Dihydropyridine Calcium Channel Blocker Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Dihydropyridine Calcium Channel Blocker Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Dihydropyridine Calcium Channel Blocker Sales by Application (2017-2022) & (K Units)
Table 53. North America Dihydropyridine Calcium Channel Blocker Sales by Application (2023-2028) & (K Units)
Table 54. North America Dihydropyridine Calcium Channel Blocker Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Dihydropyridine Calcium Channel Blocker Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Dihydropyridine Calcium Channel Blocker Sales by Country (2017-2022) & (K Units)
Table 57. North America Dihydropyridine Calcium Channel Blocker Sales by Country (2023-2028) & (K Units)
Table 58. North America Dihydropyridine Calcium Channel Blocker Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Dihydropyridine Calcium Channel Blocker Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Dihydropyridine Calcium Channel Blocker Sales by Type (2017-2022) & (K Units)
Table 61. Europe Dihydropyridine Calcium Channel Blocker Sales by Type (2023-2028) & (K Units)
Table 62. Europe Dihydropyridine Calcium Channel Blocker Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Dihydropyridine Calcium Channel Blocker Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Dihydropyridine Calcium Channel Blocker Sales by Application (2017-2022) & (K Units)
Table 65. Europe Dihydropyridine Calcium Channel Blocker Sales by Application (2023-2028) & (K Units)
Table 66. Europe Dihydropyridine Calcium Channel Blocker Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Dihydropyridine Calcium Channel Blocker Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Dihydropyridine Calcium Channel Blocker Sales by Country (2017-2022) & (K Units)
Table 69. Europe Dihydropyridine Calcium Channel Blocker Sales by Country (2023-2028) & (K Units)
Table 70. Europe Dihydropyridine Calcium Channel Blocker Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Dihydropyridine Calcium Channel Blocker Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Dihydropyridine Calcium Channel Blocker Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Dihydropyridine Calcium Channel Blocker Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Dihydropyridine Calcium Channel Blocker Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Dihydropyridine Calcium Channel Blocker Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Dihydropyridine Calcium Channel Blocker Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Dihydropyridine Calcium Channel Blocker Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Dihydropyridine Calcium Channel Blocker Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Dihydropyridine Calcium Channel Blocker Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Dihydropyridine Calcium Channel Blocker Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Dihydropyridine Calcium Channel Blocker Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Dihydropyridine Calcium Channel Blocker Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Dihydropyridine Calcium Channel Blocker Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Dihydropyridine Calcium Channel Blocker Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Dihydropyridine Calcium Channel Blocker Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Dihydropyridine Calcium Channel Blocker Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Dihydropyridine Calcium Channel Blocker Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Dihydropyridine Calcium Channel Blocker Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Dihydropyridine Calcium Channel Blocker Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Dihydropyridine Calcium Channel Blocker Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Dihydropyridine Calcium Channel Blocker Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Dihydropyridine Calcium Channel Blocker Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Dihydropyridine Calcium Channel Blocker Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Dihydropyridine Calcium Channel Blocker Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Dihydropyridine Calcium Channel Blocker Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Dihydropyridine Calcium Channel Blocker Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Dihydropyridine Calcium Channel Blocker Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Dihydropyridine Calcium Channel Blocker Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Dihydropyridine Calcium Channel Blocker Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Dihydropyridine Calcium Channel Blocker Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Dihydropyridine Calcium Channel Blocker Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Dihydropyridine Calcium Channel Blocker Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Dihydropyridine Calcium Channel Blocker Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Dihydropyridine Calcium Channel Blocker Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Dihydropyridine Calcium Channel Blocker Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Dihydropyridine Calcium Channel Blocker Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Dihydropyridine Calcium Channel Blocker Revenue by Country (2023-2028) & (US$ Million)
Table 108. Pfizer Corporation Information
Table 109. Pfizer Description and Major Businesses
Table 110. Pfizer Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 111. Pfizer Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Pfizer Recent Developments
Table 113. AstraZeneca Corporation Information
Table 114. AstraZeneca Description and Major Businesses
Table 115. AstraZeneca Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 116. AstraZeneca Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. AstraZeneca Recent Developments
Table 118. Abbott Corporation Information
Table 119. Abbott Description and Major Businesses
Table 120. Abbott Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 121. Abbott Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Abbott Recent Developments
Table 123. Novartis Corporation Information
Table 124. Novartis Description and Major Businesses
Table 125. Novartis Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 126. Novartis Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Novartis Recent Developments
Table 128. Sanofi Corporation Information
Table 129. Sanofi Description and Major Businesses
Table 130. Sanofi Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 131. Sanofi Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Sanofi Recent Developments
Table 133. Sine Promod Corporation Information
Table 134. Sine Promod Description and Major Businesses
Table 135. Sine Promod Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 136. Sine Promod Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Sine Promod Recent Developments
Table 138. Desano Corporation Information
Table 139. Desano Description and Major Businesses
Table 140. Desano Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 141. Desano Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Desano Recent Developments
Table 143. Kang Lisheng Pharma Corporation Information
Table 144. Kang Lisheng Pharma Description and Major Businesses
Table 145. Kang Lisheng Pharma Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 146. Kang Lisheng Pharma Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Kang Lisheng Pharma Recent Developments
Table 148. Guo Guang Pharma Corporation Information
Table 149. Guo Guang Pharma Description and Major Businesses
Table 150. Guo Guang Pharma Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 151. Guo Guang Pharma Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Guo Guang Pharma Recent Developments
Table 153. Baiyunshan Pharma Corporation Information
Table 154. Baiyunshan Pharma Description and Major Businesses
Table 155. Baiyunshan Pharma Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 156. Baiyunshan Pharma Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Baiyunshan Pharma Recent Developments
Table 158. Dawnrays Corporation Information
Table 159. Dawnrays Description and Major Businesses
Table 160. Dawnrays Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 161. Dawnrays Dihydropyridine Calcium Channel Blocker Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Dawnrays Recent Developments
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Dihydropyridine Calcium Channel Blocker Distributors List
Table 166. Dihydropyridine Calcium Channel Blocker Customers List
Table 167. Dihydropyridine Calcium Channel Blocker Market Trends
Table 168. Dihydropyridine Calcium Channel Blocker Market Drivers
Table 169. Dihydropyridine Calcium Channel Blocker Market Challenges
Table 170. Dihydropyridine Calcium Channel Blocker Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Dihydropyridine Calcium Channel Blocker Product Picture
Figure 2. Global Dihydropyridine Calcium Channel Blocker Market Share by Type in 2021 & 2028
Figure 3. Norvasc Product Picture
Figure 4. Plendil Product Picture
Figure 5. DynaCirc Product Picture
Figure 6. Cardene Product Picture
Figure 7. Others Product Picture
Figure 8. Global Dihydropyridine Calcium Channel Blocker Market Share by Application in 2021 & 2028
Figure 9. Hypertension
Figure 10. Coronary Artery Disease
Figure 11. Arrhythmia
Figure 12. Cardiomyopathy
Figure 13. Others
Figure 14. Dihydropyridine Calcium Channel Blocker Report Years Considered
Figure 15. Global Dihydropyridine Calcium Channel Blocker Sales 2017-2028 (K Units)
Figure 16. Global Dihydropyridine Calcium Channel Blocker Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Dihydropyridine Calcium Channel Blocker Revenue 2017-2028 (US$ Million)
Figure 18. Global Dihydropyridine Calcium Channel Blocker Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Region (2017-2022)
Figure 20. Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Region (2023-2028)
Figure 21. North America Dihydropyridine Calcium Channel Blocker Sales YoY (2017-2028) & (K Units)
Figure 22. North America Dihydropyridine Calcium Channel Blocker Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Dihydropyridine Calcium Channel Blocker Sales YoY (2017-2028) & (K Units)
Figure 24. Europe Dihydropyridine Calcium Channel Blocker Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Dihydropyridine Calcium Channel Blocker Sales YoY (2017-2028) & (K Units)
Figure 26. Asia-Pacific Dihydropyridine Calcium Channel Blocker Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Dihydropyridine Calcium Channel Blocker Sales YoY (2017-2028) & (K Units)
Figure 28. Latin America Dihydropyridine Calcium Channel Blocker Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Dihydropyridine Calcium Channel Blocker Sales YoY (2017-2028) & (K Units)
Figure 30. Middle East & Africa Dihydropyridine Calcium Channel Blocker Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Dihydropyridine Calcium Channel Blocker Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Dihydropyridine Calcium Channel Blocker in the World: Market Share by Dihydropyridine Calcium Channel Blocker Revenue in 2021
Figure 33. Global Dihydropyridine Calcium Channel Blocker Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Type (2017-2028)
Figure 35. Global Dihydropyridine Calcium Channel Blocker Revenue Market Share by Type (2017-2028)
Figure 36. Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Application (2017-2028)
Figure 37. Global Dihydropyridine Calcium Channel Blocker Revenue Market Share by Application (2017-2028)
Figure 38. North America Dihydropyridine Calcium Channel Blocker Sales Market Share by Type (2017-2028)
Figure 39. North America Dihydropyridine Calcium Channel Blocker Revenue Market Share by Type (2017-2028)
Figure 40. North America Dihydropyridine Calcium Channel Blocker Sales Market Share by Application (2017-2028)
Figure 41. North America Dihydropyridine Calcium Channel Blocker Revenue Market Share by Application (2017-2028)
Figure 42. North America Dihydropyridine Calcium Channel Blocker Sales Share by Country (2017-2028)
Figure 43. North America Dihydropyridine Calcium Channel Blocker Revenue Share by Country (2017-2028)
Figure 44. United States Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Dihydropyridine Calcium Channel Blocker Sales Market Share by Type (2017-2028)
Figure 47. Europe Dihydropyridine Calcium Channel Blocker Revenue Market Share by Type (2017-2028)
Figure 48. Europe Dihydropyridine Calcium Channel Blocker Sales Market Share by Application (2017-2028)
Figure 49. Europe Dihydropyridine Calcium Channel Blocker Revenue Market Share by Application (2017-2028)
Figure 50. Europe Dihydropyridine Calcium Channel Blocker Sales Share by Country (2017-2028)
Figure 51. Europe Dihydropyridine Calcium Channel Blocker Revenue Share by Country (2017-2028)
Figure 52. Germany Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 53. France Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Dihydropyridine Calcium Channel Blocker Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Dihydropyridine Calcium Channel Blocker Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Dihydropyridine Calcium Channel Blocker Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Dihydropyridine Calcium Channel Blocker Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Dihydropyridine Calcium Channel Blocker Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Dihydropyridine Calcium Channel Blocker Revenue Share by Region (2017-2028)
Figure 63. China Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 66. India Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 68. China Taiwan Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Dihydropyridine Calcium Channel Blocker Sales Market Share by Type (2017-2028)
Figure 73. Latin America Dihydropyridine Calcium Channel Blocker Revenue Market Share by Type (2017-2028)
Figure 74. Latin America Dihydropyridine Calcium Channel Blocker Sales Market Share by Application (2017-2028)
Figure 75. Latin America Dihydropyridine Calcium Channel Blocker Revenue Market Share by Application (2017-2028)
Figure 76. Latin America Dihydropyridine Calcium Channel Blocker Sales Share by Country (2017-2028)
Figure 77. Latin America Dihydropyridine Calcium Channel Blocker Revenue Share by Country (2017-2028)
Figure 78. Mexico Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Dihydropyridine Calcium Channel Blocker Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Dihydropyridine Calcium Channel Blocker Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Dihydropyridine Calcium Channel Blocker Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Dihydropyridine Calcium Channel Blocker Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Dihydropyridine Calcium Channel Blocker Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Dihydropyridine Calcium Channel Blocker Revenue Share by Country (2017-2028)
Figure 87. Turkey Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 89. UAE Dihydropyridine Calcium Channel Blocker Revenue (2017-2028) & (US$ Million)
Figure 90. Dihydropyridine Calcium Channel Blocker Value Chain
Figure 91. Dihydropyridine Calcium Channel Blocker Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed